A. Uijl

发表

Association Between Use of Primary Prevention Implantable Cardioverter-Defibrillators and Mortality in Patients with Heart Failure: A Prospective Propensity-Score Matched Analysis from the Swedish Heart Failure Registry.

M. Ståhlberg, F. Braunschweig, D. Westermann, 2019, Circulation.

Association Between β-Blocker Use and Mortality/Morbidity in Patients With Heart Failure With Reduced, Midrange, and Preserved Ejection Fraction and Advanced Chronic Kidney Disease

L. Lund, J. Carrero, F. Dekker, 2020, Circulation. Heart failure.

Antithrombotic Therapy and Major Adverse Limb Events in Patients With Chronic Lower Extremity Arterial Disease: Systematic Review and Meta-analysis from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy in Collaboration with the European Society of Cardiology Working

D. Atar, B. Lewis, L. Lund, 2019, European heart journal. Cardiovascular pharmacotherapy.

Empagliflozin in Heart Failure With Predicted Preserved Versus Reduced Ejection Fraction: Data From the EMPA-REG OUTCOME Trial.

L. Lund, S. Anker, J. Butler, 2021, Journal of cardiac failure.

A registry‐based algorithm to predict ejection fraction in patients with heart failure

A. Hoes, L. Lund, F. Asselbergs, 2020, ESC heart failure.

Generalizability of randomized controlled trials in heart failure with reduced ejection fraction

B. Tyl, A. Hoes, D. Grobbee, 2021 .

Sex-Based Differences in Heart Failure Across the Ejection Fraction Spectrum: Phenotyping, and Prognostic and Therapeutic Implications.

A. Strömberg, G. Rosano, G. Sinagra, 2019, JACC. Heart failure.

The GUIDE‐IT heart failure risk prediction model: another fish in the sea?

L. Lund, G. Savarese, A. Uijl, 2019, European journal of heart failure.

Clinical profile and contemporary management of patients with heart failure with preserved ejection fraction: results from the CHECK-HF registry

A. Hoes, F. Asselbergs, G. Linssen, 2021, Netherlands Heart Journal.

Early recurrences of atrial tachyarrhythmias post pulmonary vein isolation

H. Bastani, N. Drca, P. Insulander, 2020, Journal of cardiovascular electrophysiology.

Cardiac resynchronization therapy with or without defibrillator in patients with heart failure

L. Lund, F. Braunschweig, C. Linde, 2021, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Methodological issues in meta-analyses of real-world clinical data to infer causality.

L. Lund, F. Asselbergs, G. Savarese, 2021, International journal of cardiology.

Generalizability of randomized controlled trials in heart failure with reduced ejection fraction

B. Tyl, A. Hoes, L. Lund, 2021, European heart journal. Quality of care & clinical outcomes.

Risk for Heart Failure: The Opportunity for Prevention With the American Heart Association's Life's Simple 7.

J. Boer, A. Hoes, W. Verschuren, 2019, JACC. Heart failure.

Temporal trends in heart failure medication prescription in a population-based cohort study

A. Hoes, D. Grobbee, S. Denaxas, 2021, BMJ Open.

Preventing heart failure: a position paper of the Heart Failure Association in collaboration with the European Association of Preventive Cardiology

K. Sliwa, I. Piña, S. Heymans, 2022, European journal of heart failure.

Clinical presentation, disease course and outcome of COVID-19 in hospitalized patients with and without pre-existing cardiac disease: a cohort study across sixteen countries

J. De Sutter, P. Woudstra, P. van der Harst, 2021, medRxiv.

Identification of distinct phenotypic clusters in heart failure with preserved ejection fraction

A. Hoes, L. Lund, F. Asselbergs, 2021, European journal of heart failure.

Prevalence and Prognostic Implications of Longitudinal Ejection Fraction Change in Heart Failure.

L. Lund, G. Rosano, U. Dahlström, 2019, JACC. Heart failure.

Association between beta‐blocker use and mortality/morbidity in older patients with heart failure with reduced ejection fraction. A propensity score‐matched analysis from the Swedish Heart Failure Registry

G. Rosano, F. Asselbergs, G. Sinagra, 2019, European Journal of Heart Failure.

Biomarker changes as surrogate endpoints in early‐phase trials in heart failure with reduced ejection fraction

N. Samani, K. Dickstein, L. Lund, 2022, ESC heart failure.

Risk factors for incident heart failure in age‐ and sex‐specific strata: a population‐based cohort using linked electronic health records

A. Banerjee, A. Hoes, S. Denaxas, 2019, European journal of heart failure.

Discovering Distinct Phenotypical Clusters in Heart Failure Across the Ejection Fraction Spectrum: a Systematic Review

F. Asselbergs, M. L. Handoko, G. Savarese, 2023, Current Heart Failure Reports.

Internal-external cross-validation helped to evaluate the generalizability of prediction models in large clustered datasets.

S. Denaxas, F. Asselbergs, K. Snell, 2021, Journal of clinical epidemiology.

Multimorbidity in Heart Failure: Leveraging Cluster Analysis to Guide Tailored Treatment Strategies

F. Asselbergs, G. Savarese, J. Beulens, 2023, Current Heart Failure Reports.

Does Heterogeneity Exist in Treatment Associations with Renin-Angiotensin-System Inhibitors or Beta-blockers According to Phenotype Clusters in Heart Failure with Preserved Ejection Fraction?

L. Lund, F. Asselbergs, U. Dahlström, 2023, Journal of cardiac failure.

Sex differences in the generalizability of randomized clinical trials in heart failure with reduced ejection fraction

B. Tyl, A. Hoes, L. Lund, 2023, European journal of heart failure.